Who has invested in NexImmune?

Multiple Myeloma Research Foundation are named among the investors backing NexImmune.

NexImmune Funding: $200M Raised, IPO (2021)

NexImmune funding overview

NexImmune is based in Baltimore, Maryland. NexImmune has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in February 2021. The round record for NexImmune runs through 2021; nothing later has been disclosed. Investors on record include Multiple Myeloma Research Foundation.

NexImmune at a glance

Total raised: $200M
Latest round: IPO
Latest round date: February 2021
Headquarters: Baltimore, Maryland
Notable investors: Multiple Myeloma Research Foundation

Frequently asked about NexImmune funding

How much has NexImmune raised?: NexImmune has raised $200M in total disclosed funding across the rounds on record.
Who has invested in NexImmune?: Multiple Myeloma Research Foundation are named among the investors backing NexImmune.
What was the latest NexImmune funding round?: The most recent disclosed round is an IPO, announced in February 2021.
Where is NexImmune based?: NexImmune is based in Baltimore, Maryland.
When did NexImmune last raise?: The last disclosed NexImmune round closed in February 2021 at IPO.

Round data for NexImmune is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Baltimore and backer lists below.

NexImmune Funding: $200M Raised, IPO (2021)

NexImmune funding overview

NexImmune at a glance

Frequently asked about NexImmune funding

Companies related to NexImmune (18)

Browse related funding lists (3)